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Abstract The NH2-terminal end of a protein, named SMCp,
which contains an ARID (A/T rich interaction domain) DNA
binding domain and is similar to the mammalian SMCY/SMCX
proteins and retinoblastoma binding protein 2, was shown to bind
the African swine fever virus encoded ubiquitin conjugating
enzyme (UBCv1) using the yeast two hybrid system and in in
vitro binding assays. Antisera raised against the SMCp protein
were used to show that the protein is present in the cell nucleus.
Immunofluorescence showed that although UBCv1 is present in
the nucleus in most cells, in some cells it is in the cytoplasm,
suggesting that it shuttles between the nucleus and cytoplasm.
The interaction and co-localisation of UBCv1 with SMCp
suggest that SMCp may be a substrate in vivo for the enzyme.
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1. Introduction
African swine fever virus (ASFV) is a large DNA virus
which replicates in the cytoplasm of infected cells and has a
tropism for macrophages. The 170 kb genome [8,32] encodes
the only known virus encoded ubiquitin conjugating enzyme,
UBCv1 [15,27].
These enzymes catalyse the attachment of ubiquitin to sub-
strate proteins which tags them for proteolytic degradation
via the proteasome. In addition to UBC enzymes, ubiquitin
activating and E3 or ubiquitin protein ligase enzymes (for
review see [6,14,28,29]) are involved in attaching ubiquitin
to substrate proteins. Selective protein degradation mediated
by protein ubiquitination regulates many processes including
transcription and cell cycle control [6,26,29].
Recombinant UBCv1 can, in vitro, ubiquitinate itself as
well as histones and an ASFV virion protein, PIG1 [15,16].
However, it is not known whether these are in vivo sub-
strate(s) for the enzyme. To investigate putative substrates
for UBCv1, we identi¢ed interacting host proteins using the
yeast two hybrid system. Among the UBCv1 interacting pro-
teins was a truncated protein containing 215 amino acids in-
cluding an ARID (A/T rich interaction domain) DNA binding
domain. This protein, named SMCp, is very similar to the
SMCX/Y [1,31] and retinoblastoma binding protein 2
(RBBP2) [10]. We demonstrated speci¢c binding in vitro of
UBCv1 to this 215 amino acid domain of SMCp and showed
that both proteins are predominantly localised in the nucleus
in cells. These results suggest either that SMCp is an in vivo
substrate for UBCv1 or that the interaction targets UBCv1 to
another substrate.
2. Materials and methods
2.1. Cells and viruses
Primary lamb testis (LT), bovine kidney (BK) cells, IBRS2
(ECACC 84100503), RK-13 (ECACC 88062427), HeLa (ECACC
84121901), CHO-K1 (ECACC 85051005), Vero (ECACC 84113001)
and BSC 1 (ECACC 85011422) cells were grown under 5% CO2 at
37‡C in HEPES bu¡ered Dulbecco’s modi¢ed Eagle’s medium sup-
plemented with 10% foetal calf serum. BA71V tissue culture adapted
ASFV isolate has been described previously [4].
2.2. Plasmids
A SmaI, SalI fragment containing the UBCv1 gene was cloned into
pAS2-CYH2 (Clontech) as an in frame fusion with the GAL4 DNA
binding domain. The insert in the plasmid was sequenced to con¢rm
that the UBCv1 ORF was in frame with the GAL4 DNA binding
domain.
SMCp was ampli¢ed by PCR from the pACT2.6 AD plasmid,
using primers SMCp-FOR; AAA GGA TCC ATG GAG CCG
GGG TCA GAC G and SMCp-REV; AAA GAA TTC GGG TTT
TTC AGT ATC TAC GAT TC. The ampli¢ed fragment of 650 bp
was digested with the BamHI and EcoRI and ligated into pGEX2TK
vector (Pharmacia-Amersham) to give the pGEX2TK-SMCp plasmid.
The UBCv1 gene was cloned as a BamHI fragment downstream and
in frame with an eight amino acid epitope tag derived from human
in£uenza virus haemagglutinin (HA) protein to give pCDNA-HA-
UBCv1.
The HA tagged UBCv1 gene cassette was released from pCDNA-
HA-UBCv1 using HindIII and XbaI, end repaired and ligated to SmaI
digested p32-OP plasmid (L.K. Dixon and C.C. Abrams, unpublished
results), downstream of the ASFV early/late p32 promoter [25] in the
pT7 plasmid (Invitrogen), to give the plasmid p32-OP-HA-UBCv1.
Primers NLS Mut1 (5P-GAT CTA CTA GTC ATA TGG ATT
GG-3P) and NLS Mut2 (5P-ATT CTA GAT CCT CTT TAT ATA
GAT ATT TAC GGT AG-3P) were used to amplify 700 bp containing
the p32 promoter, the HA epitope and the 5P portion of UBCv1 up-
stream of the putative NLS. Primers NLS Mut3 (5P-GAG GAT CTA
GAA TCA TAC CCC ATG GAA GAG TGT TCA GCG GAA
GAC ATA G-3P) and NLS Mut4 (5P-GTG TGA CTA TAG CTA
CTC ATC ATC CAT CTC TT-3P) ampli¢ed 200 bp of the 3P termi-
nus of UBCv1 after the putative NLS. The 700 bp and 200 bp PCR
fragments were digested at XbaI sites within the primers, ligated to-
gether and then cloned into pT7Blue2 to give p32-OP-HA-UBCv1
(NLS Mut). The 700 bp 5P fragment was also cloned separately into
pCDNA3 giving p32-OP-HA-UBCv1 vC.
2.3. Yeast two hybrid screen
pAS2-UBCv1 plasmid was co-transformed with a porcine macro-
phage cDNA library [23] into yeast strain Y190. Colonies containing
plasmids encoding UBCv1 interacting proteins were selected by grow-
ing on medium lacking histidine in the presence of 25 mM 3-amino-
triazole. Speci¢city of the interaction with UBCv1 was con¢rmed by
retransformation into yeast with either the pAS2-UBCv1 plasmid or
other control plasmids and testing for expression of the Gal 4 depen-
dent reporter L-galactosidase. Inserts in plasmids were sequenced and
sequences compared with sequence databases using BLAST [2,3].
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2.4. Immuno£uorescence
Vero cells were grown on coverslips, infected with BA71V virus and
transfected with 10 Wg of the appropriate plasmid. After overnight
incubation coverslips were ¢xed in 3% paraformaldehyde and permea-
bilised with 0.2% (w/v) Triton X-100. After washing, cells were
blocked in 0.2% gelatin in phosphate bu¡ered saline at room temper-
ature and incubated with rat anti-HA primary antibody (1/100) fol-
lowed by FITC conjugated secondary goat anti-rat antibody (1/50),
then mounted in Mowiol (Hoechst) and examined using a £uorescence
microscope.
2.5. RT-PCR ampli¢cation of SMCp and SMCp-like genes
Total RNA from cell lines or pig tissues was isolated using the
Qiagen total RNA extraction kit. RT-PCR was carried out using
primers SMCp-FOR and SMCp-REV.
2.6. Expression of GST and GST fusion proteins
Expression of the GST or GST^SMCp fusion proteins was induced
in Escherichia coli transformed with either pGEX2TK or pGEX2TK-
SMCp plasmids by adding IPTG to 0.1 mM. Proteins extracted from
bacteria were a⁄nity puri¢ed using glutathione Sepharose beads
(Pharmacia-Amersham) and analysed by SDS^PAGE followed by
staining with Coomassie brilliant blue.
2.7. Binding of HA-UBCv1 to SMCp
Radiolabelled HA-UBCv1 was produced by in vitro transcription
and translation from plasmid pCDNA-HA-UBCv1 (Promega TNT).
Bacterially expressed GST and GST^SMCp fusion protein were
bound to glutathione Sepharose beads (Pharmacia-Amersham) and
incubated at 4‡C overnight with radiolabelled in vitro translated
HA-UBCv1 at varying salt concentrations (50^200 mM NaCl) in 50
mM Tris^HCl pH 7.5, 0.1% (v/v) NP40. The beads were washed three
times in the binding bu¡er and bound proteins separated by SDS^
PAGE and visualised by £uorography.
2.8. Production of antibodies against SMCp
75 Wg of puri¢ed GST^SMCp protein was inoculated into a rabbit
at 2 week intervals both intramuscularly and subcutaneously in
Freund’s complete adjuvant. Serum was collected at day 54 post in-
oculation and anti-SMCp antibodies were puri¢ed by passing through
a column containing GST coupled to Sepharose 4B beads (Pharma-
cia-Amersham). The £owthrough was loaded onto a column contain-
ing GST^SMCp coupled to Sepharose 4B beads and bound SMCp
speci¢c antibodies were eluted with 100 mM glycine^HCl, pH 2.5
bu¡er.
3. Results
3.1. Identi¢cation of pig proteins which bind UBCv1
To identify cellular proteins that may be substrates for
UBCv1, we looked for proteins that interact with this enzyme
by screening a pig alveolar macrophage cDNA library [23]
using the yeast two hybrid system [5,9]. A plasmid vector
(pAS2-UBCv1) that expressed UBCv1 protein as a fusion
with the DNA binding domain of GAL4 was used as bait.
Four colonies containing plasmids that expressed UBCv1
interacting proteins were isolated. Plasmids were isolated
from these clones and retransformed into yeast together
with the pAS2-UBCv1 plasmid or an irrelevant GAL4 DNA
binding domain fusion (pGBT9-A238L) and assayed for ex-
pression of L-galactosidase (L-gal; Table 1). This con¢rmed
that the interaction between UBCv1 and the proteins encoded
by the four library clones was speci¢c. DNA inserts from the
library clones were sequenced and searched against DNA da-
tabases using BLAST [2,3]. Three of the four positive clones
contained cDNAs encoding ubiquitin and shared 100% amino
acid identity at the protein level with porcine and human
ubiquitin. Each of these also contained nucleotide sequences
downstream of the ubiquitin open reading frame showing that
they were ubiquitin fusions with other genes. This is expected
because ubiquitin is always expressed either as polyubiquitin
or fused with other proteins [12,20,21,24,30].
One of the clones encoding a UBCv1 interacting protein
(pACT2.6) contained a truncated part of a gene encoding a
protein we designated SMCp. Within a 581 bp overlap, this
SMCp gene shared 93% nucleotide identity with the 5P region
of the gene encoding human SMCX protein. At the protein
level, the SMCp encoded protein shared 94% amino acid iden-
tity with human SMCX and 88% with the human SMCY
proteins over the NH2-terminal 201 amino acids (Fig. 1),
69% identity with human RBBP2 over 168 amino acids and
47% identity with the mouse Jumonji protein over 156 amino
acids. SMCX, SMCY, RBBP2 and Jumonji contain ARID
DNA binding domains which are involved in eukaryotic
gene regulation [13]. The ARID domain is contained within
the region of the SMCp protein encoded by pACT2.6.
3.2. UBCv1 binds to SMCp in vitro
To con¢rm the interaction observed between UBCv1 and
SMCp we carried out binding assays using in vitro translated
HA-UBCv1 and recombinant GST^SMCp proteins. Expres-
sion of the GST^SMCp protein (54 kDa) was induced by
addition of IPTG to E. coli cultures containing the
pGEXTK-SMCp plasmid. The UBCv1 gene fused down-
stream of a sequence encoding the HA epitope tag under
the control of the T7 promoter in the pCDNA3 vector
(pCDNA3-HA-UBCv1) was transcribed and translated in vi-
tro to produce radiolabelled HA-UBCv1 (Fig. 2, lane 7). The
GST^SMCp fusion protein and a control GST protein were
bound to glutathione Sepharose beads and incubated over-
night at 4‡C with [35S]methionine labelled HA-UBCv1 in
binding bu¡er containing varying concentrations of NaCl
(50, 100 and 200 mM). The beads were collected and washed
in binding bu¡er, then proteins were separated by SDS^
Table 1
Yeast two hybrid screen of pig macrophage cDNA library with UBCv1 gene
Bd plasmid Ad plasmid L-Gal expression Database matches Nucleotide identity (%)
pAS2-UBCv1 none no
pAS2-UBCv1 pACT2-A238L no
pAS2-UBCv1 pACT2.5 yes H. sapiens Uba80 mRNA for ubiquitin; X63237 466/503 = 92%
pAS2-UBCv1 pACT2.6 yes H. sapiens XE169mRNA; L25270 544/581 = 93%
pAS2-UBCv1 pACT2.46 yes H. sapiens Uba80 mRNA for ubiquitin X63237 442/478 = 92%
pAS2-UBCv1 pACT2.R yes pig poly-ubiquitin mRNA M18159 483/483 = 100%
The plasmids used as the Gal4 DNA binding domains (Bd plasmid) or activation domains (Ad plasmid) are indicated. Activation of the Gal 4
dependent L-galactosidase gene was assayed using a colony lift assay [9]. Sequences of inserts from clones isolated from a pig macrophage
cDNA library encoding proteins that interact with UBCv1 were compared with databases and those entries showing the highest similarity are
indicated together with the % nucleotide identity and length of sequence over which this identity is measured.
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Fig. 1. Alignment of SMCp protein with related SMCX/Y and RBBP2 proteins. A: Alignment of the SMCp protein sequence (5) with similar
SMCX/Y and RBBP2 proteins. The GCG pretty box program was used to align the sequences. Sequences shown are human SMCY protein
(1), human SMCY (H-Y) protein (2), human XE169 protein (3), human SMCX protein (4), Mus domesticus SMCX protein (6), Equus caballus
SMCX protein (7), Equus caballus SMCY protein (8), Mus musculus (BALB/c) SMCY protein (9) and human retinoblastoma binding protein 2
(10). Black shading shows identical residues; grey shading indicates similar residues. The last line of sequences corresponds to a computed con-
sensus sequence. B: Conserved domain in SMCX, RBBP2 and Jumonji (JJ) proteins. Regions conserved between the SMCX/Y, RBP2 and Ju-
monji proteins are shown in black. Regions of similarity between SMCX/Y and RBP2 but not Jumonji proteins are shown in grey. The per-
centage amino acid identity between two adjacent protein sequences in the alignment is indicated.
FEBS 23491 30-3-00
W.D. Bulimo et al./FEBS Letters 471 (2000) 17^22 19
PAGE and radiolabelled proteins detected by £uorography.
Binding of HA-UBCv1 to GST^SMCp was detected at NaCl
concentrations between 50 and 200 mM (Fig. 2, lanes 1^3) but
no binding to the control GST protein was detected (Fig. 2,
lanes 4^6). These results con¢rm that UBCv1 binds speci¢-
cally to the 192 N-terminal domain of SMCp. Due to the very
large size of SMCX/SMCY and RBP2 binding proteins
(s 1500 amino acids), expression of the full length protein
would be technically very di⁄cult to achieve and may not
produce correctly folded protein. The 215 amino acid region
of the protein we used in binding studies contains the intact
ARID DNA binding domain which lies between residues 76
and 184. To ful¢ll its function, this region of the protein is
likely to be exposed on the surface of the intact SMCp pro-
tein. Moreover, DNA binding domains from transcription
regulators have been shown to retain their function when ex-
pressed separately from the rest of the protein or as fusions
with other proteins [11,18]. Thus we expect this part of the
protein to be correctly folded when expressed as a separate
domain. The speci¢c binding we observed between UBCv1
and the truncated N-terminal domain of SMCp is therefore
likely to be true for the intact SMCp protein.
3.3. Transcripts of SMCp are present in a wide range of tissues
and cell lines
The presence of SMCp transcripts in various pig tissues was
studied by RT-PCR. A band of the expected size (650 bp) was
ampli¢ed from RNA from ovary, brain, liver, spleen, skeletal
and cardiac muscle whereas no bands were ampli¢ed in con-
trol experiments (Fig. 3). The human SMCX gene is similarly
expressed in a wide variety of tissues [31].
To determine if the SMCp gene is conserved in di¡erent
species, its expression in a variety of mammalian primary
and di¡erentiated cells was studied by RT-PCR. The expected
650 bp fragment was ampli¢ed from Vero (monkey kidney),
BSC1 (monkey kidney), HeLa (human epithelial), RK13 (rab-
bit kidney), IBRS2 (pig kidney), LT (lamb testis), BK (bovine
kidney) and CHO-K1 (Chinese hamster ovary) cells (Fig. 3).
Previous studies have shown that SMC genes are expressed in
many tissues of all mammalian species including wallaby and
Monodelphis domestica (metatherians), human, horse, dog,
mouse, cattle, sheep and rabbits (eutherians [19]). These ob-
servations, combined with the high sequence similarity, sup-
port the suggestion that SMCp is a porcine homologue of
SMCX/Y proteins.
3.4. SMCp localises to the nucleus of ASFV infected cells
We studied subcellular localisation of SMCp and UBCv1 to
determine if the proteins could interact in ASFV infected cells.
A rabbit was immunised with bacterially expressed GST^
SMCp and anti-SMCp speci¢c antibodies were puri¢ed by
a⁄nity chromatography. Western blotting con¢rmed that
this puri¢ed antibody speci¢cally recognised the bacterially
expressed SMCp protein cleaved from the GST^SMCp fusion
(data not shown). This antibody was used to determine the
subcellular localisation of SMCp in uninfected and ASFV
infected Vero cells using indirect immuno£uorescence. This
showed that SMCp localised to the nucleus of all cells (Fig.
4d). No staining was observed using non-immune rabbit sera,
nor with either primary or secondary antibody alone (data not
shown).
3.5. UBCv1 localises mainly to the nuclei of ASFV infected
cells
To study the subcellular localisation of UBCv1 in ASFV
infected cells, a plasmid with the HA epitope fused to the
UBCv1 gene under the control of the strong early/late p32
ASFV promoter was transfected into Vero cells infected
with ASFV BA71V isolate. The HA tagged UBCv1 enzyme
was detected using a rat anti-HA monoclonal antibody and
FITC conjugated goat anti-rat secondary antibody. In a small
proportion of the cells staining was localised to the cytoplasm
alone and in a few cells both the cytoplasm and the nucleus
were stained (Fig. 4a,b). However, the majority of the cells
displayed staining localised to the nucleus alone (Fig. 4c). No
staining was observed in cells reacted with primary or second-
ary antibody alone nor in cells which were infected but not
transfected (data not shown). These observations suggested
that HA-UBCv1 shuttles between the cytoplasm and the nu-
cleus of ASFV infected cells but is mainly located in the nu-
cleus.
UBCv1 contains the amino acid sequence, VKKTVKK-
SLD, towards its carboxy-terminus, residues 161^170, which
is similar to the nuclear localisation signal (NLS) of human
c-myc protein [22]. To test whether this sequence is needed for
the transport of UBCv1 into the nucleus, the sequence encod-
ing these residues was deleted from UBCv1. This plasmid
Fig. 2. In vitro translated HA-UBCv1 binds to GST-SMCp but not
to GST proteins. Bacterially expressed GST^SMCp and GST pro-
teins were bound to glutathione Sepharose beads and incubated
with in vitro transcribed and in vitro translated radiolabelled HA-
UBCv1 in the presence of SMCp binding bu¡er (see Section 2) con-
taining 50 mM (lanes 1 and 4), 100 mM (lanes 2 and 5), or 200
mM (lanes 3 and 6) NaCl and 0.1% NP40. Beads were washed
three times with the binding bu¡er and bound proteins eluted with
SDS^PAGE sample bu¡er, then separated by 10% SDS^PAGE.
Bound HA-UBCv1 was visualised by £uorography after separation
of the proteins using SDS^PAGE.
Fig. 3. SMCp is transcribed in a wide variety of tissues and cell
lines. Total RNA was prepared from pig tissues or cell lines and
RT PCR carried out using primers speci¢c for the SMCp gene.
Lanes 1 and 10 show a 100 bp ladder, lanes 2^7 PCR products am-
pli¢ed from the following tissues: 2 ovary, 3 cardiac muscle, 4 brain,
5 liver, 6 spleen, 7 skeletal muscle, and cell lines, 11 HeLa, 12 Vero,
13 CHO, 14 IBRS2, 15 RK, 16 BSC-1, 17 BK, 18 LT. Lanes 8 and
9 show control reactions containing either no primers (8) or an
RNase treated sample (9).
FEBS 23491 30-3-00
W.D. Bulimo et al./FEBS Letters 471 (2000) 17^2220
(p32-OP-HA-UBCv1 NLS Mut) was transfected into ASFV
infected Vero cells and the HA-UBCv1 detected by immuno-
£uorescence using anti-HA antibodies. This mutant HA-
UBCv1 still localised almost entirely in the nucleus of most
transfected cells (Fig. 4e) showing that the VKKTVKKSLD
sequence is not required for accumulation of UBCv1 in the
nucleus.
UBC enzymes with acidic carboxy-terminal extensions sim-
ilar to that of UBCv1 conjugate ubiquitin to their substrates
in an E3 independent manner in vitro, indicating that they
interact directly with their substrates [17]. The acidic C-termi-
ni of such enzymes are not only involved in substrate recog-
nition but are also thought to dictate the intracellular local-
isation of the enzyme [17]. To test whether the UBCv1 acidic
tail mediates the nuclear accumulation of UBCv1, sequences
encoding residues 160^223 were deleted from the UBCv1 gene
(p32-OP-HA-UBCv1vC). The plasmid expressing this mutant
UBCv1 was transfected into ASFV infected Vero cells and the
HA-UBCv1 detected by immuno£uorescence. No cells were
found with UBCv1 localised entirely in the nucleus, instead,
in most cells equal amounts of UBCv1 were seen in the nu-
cleus and the cytoplasm (Fig. 4f). This suggests that the acidic
tail is required for an accumulation of UBCv1 in the nucleus.
4. Discussion
Many cellular proteins that control regulatory pathways are
selectively degraded by the ubiquitin/proteasome pathway (re-
viewed in [6,7]). UBC enzymes are central to this process. One
way to decipher the role of the UBCv1 enzyme encoded by
ASFV is to determine protein(s) which UBCv1 targets for
ubiquitination and thus degradation. The substrate(s) may
be either host or virus encoded. We used the yeast two hybrid
system to identify host proteins that bind to UBCv1 and
which might, therefore, be enzyme substrates. Of the four
clones encoding proteins which interacted speci¢cally with
UBCv1, three encoded ubiquitin. All UBC enzymes must in-
teract with ubiquitin as they transfer the ubiquitin to substrate
proteins; the demonstration that UBCv1 bound to ubiquitin
provided evidence that the two hybrid screen had worked
e⁄ciently. One clone encoded a UBCv1 interacting protein
that was homologous at the amino acid level to a fragment
of the SMCX/Y proteins. This gene, designated SMCp, is very
similar to the N-terminal region of the mammalian SMCX/Y
genes (93% nucleotide identity) and RBBP2 (69% amino acid
identity). The conservation of SMCp in di¡erent species, ex-
pression in many di¡erent tissues and sequence similarity with
SMCX/Y genes, suggest it is the porcine homologue of these
genes. Further evidence that UBCv1 binds to SMCp was pro-
vided by in vitro binding studies using the N-terminal 215
amino acids of SMCp expressed as a fusion with GST. This
region of the SMCp protein contains the intact ARID DNA
binding domain (residues 76^184), which is likely to be ex-
posed on the surface of the intact protein and to be correctly
folded since DNA binding domains can retain their function
when expressed either alone or as fusions with other proteins.
We therefore expect that UBCv1 would also bind speci¢cally
to this region of the intact SMCp protein. Due to the very
large predicted size of SMCp (s 1500 amino acids) it was
technically not feasible to express the intact SMCp protein
either in vitro or in E. coli and to test for direct binding of
UBCv1 to the intact SMCp protein. Further evidence for
interaction between UBCv1 and SMCp in infected cells was
provided by immuno£uorescence showing that the two pro-
teins co-localise in the nucleus. UBCv1 is present almost en-
tirely in the nucleus in most cells but is present in the cyto-
plasm in some cells. This suggests that UBCv1 shuttles
between nucleus and cytoplasm. The signals which regulate
this have not been de¢ned. Mutagenesis of the UBCv1 se-
quence showed that the acidic C-terminal extension of
UBCv1 is required for preferential accumulation of UBCv1
in the nucleus suggesting that interactions with this domain
direct nuclear accumulation of UBCv1.
SMCX, SMCY, RBBP2 and Jumonji belong to the ARID
family of proteins which have a conserved DNA binding do-
main involved in transcriptional regulation [13]. Within the
ARID family tree, RBBP2 and SMCX cluster together sug-
gesting that they are a subfamily and may have similar roles.
In mice and humans, SMCX is expressed in all male and
female tissues tested and escapes X-inactivation [1]. Con-
Fig. 4. Localisation of wild type and mutant HA-UBCv1 and
SMCP proteins. Vero cells were infected with ASFV BA71V isolate
and transfected with vp32-OP-HA-UBCv1 (panels a, b and c),
vp32-OP-HA-UBCv1 (NLS Mut) (panel e), vp32-OP-HA-UBCv1 v
C (panel f) or untransfected (panel d). At 16 h post infection the
cells were ¢xed in 3% paraformaldehyde, permeabilised using 0.2%
Triton X-100, probed with either a rat anti-HA monoclonal (1/100
dilution) (panels a, b, c, e and f) or rabbit anti-SMCp (panel d)
sera (1/100 dilution) and with the appropriate FITC stained second-
ary antibody (rabbit anti-rat or goat anti-rabbit 1/100). Slides were
visualised using a £uorescence microscope and photographed at
400-fold magni¢cation.
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versely, SMCY is a male speci¢c gene encoded by the Y chro-
mosome and is also expressed in all male tissues tested. Ki-
netic studies of SMCY and SMCX expression in mice and
primates showed that both genes are expressed early in life
(at the two cell stage in mouse preimplantation embryos and
at the four cell stage in primates [19]). Since SMCY and
SMCX are expressed early in embryos and SMCX escapes
X-inactivation, SMC genes may be essential and both copies
necessary for normal function. The ARID domain is present
within the region of SMCp which interacts with UBCv1 sug-
gesting that this may be the interacting domain. The close
similarity between this domain in SMCX/SMCY proteins
and RBBP2 protein suggests that UBCv1 might also bind to
the RBBP2 protein.
Interaction of SMCp with UBCv1 suggests that it may be a
substrate for the enzyme and consequently be targeted for
ubiquitin dependent degradation. Thus, the role of the
UBCv1 enzyme during virus infection may be to interfere
with SMCp function by targeting it for destruction. Since
virus genes are usually captured from the host and can mimic
the function of host genes, the implication is that there may be
cellular proteins which have similar roles to that of UBCv1.
By understanding how UBCv1 functions we may learn more
about the function and regulation of ARID family proteins.
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